World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
15143
World Ranking
2352
National Ranking
94

Overview

Denis J. Moss is affiliated with the QIMR Berghofer Medical Research Institute in Australia. This association situates them within a prominent environment for medical research, contributing to scientific knowledge and clinical advancements.

The available data does not list any recent papers, frequent co-authors, or specific publication venues related to Denis J. Moss. Likewise, there are no provided details on book publications or explicit fields and subfields of study.

Due to the absence of detailed publication or topic information, it is not possible to outline specific research themes or scholarly contributions. Similarly, there are no recorded awards or honors for this scientist in the provided data.

This profile reflects the available factual information about Denis J. Moss, focusing on institutional affiliation without extrapolation beyond the data presented.

Best Publications

  • HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION

    Alan B. Rickinson;Denis J. Moss

  • Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

    R Khanna;S R Burrows;M G Kurilla;C A Jacob

  • Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

    D. J. Moss;A. B. Rickinson;J. H. Pope

  • Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

    Rajiv Khanna;Scott Bell;Martina Sherritt;Andrew Galbraith

  • Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

    Victor P. Argaet;Christopher W. Schmidt;Scott R. Burrows;Sharon L. Silins

  • An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.

    S R Burrows;R Khanna;J M Burrows;D J Moss

  • HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading

    Chen Au Peh;Scott R Burrows;Megan Barnden;Rajiv Khanna

  • Immune regulation in Epstein-Barr virus-associated diseases.

    R Khanna;S R Burrows;D J Moss

  • New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.

    L. S. Young;Q. Y. Yao;C. M. Rooney;T. B. Sculley

  • Identification of ataxia telangiectasia heterozygotes, a cancer prone population

    Philip C. Chen;Philip C. Chen;Martin F. Lavin;Chev Kidson;Chev Kidson;Denis Moss

  • Long-term T-cell-mediated immunity to Epstein-Barr virus.

    A. B. Rickinson;D. J. Moss;L. E. Wallace;M. Rowe

  • Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expression

    Martin Rowe;Rajiv Khanna;Catherine A. Jacob;Victor Argaet

  • The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

    Lisa M Ebert;Bee Shin Tan;Judy Browning;Suzanne Svobodova

  • Delivery of Multiple CD8 Cytotoxic T Cell Epitopes by DNA Vaccination

    Scott A. Thomson;Martina A. Sherritt;Jill Medveczky;Suzanne L. Elliott

  • Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity

    Scott R. Burrows;Sharon L. Silins;Rajiv Khanna;Jacqueline M. Burrows

  • Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

    D. J. Moss;I. S. Misko;S. R. Burrows;K. Burman

  • T Cell Receptor Repertoire for a Viral Epitope in Humans Is Diversified by Tolerance to a Background Major Histocompatibility Complex Antigen

    S R Burrows;S L Silins;D J Moss;R Khanna

  • Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy

    Corey Smith;Janice Tsang;Leone Beagley;Daniel T Chua

  • An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).

    S R Burrows;T B Sculley;I S Misko;C Schmidt

  • Coinfection with A and B-Type Epstein-Barr Virus in Human Immunodeficiency Virus-Positive Subjects

    Tom B. Sculley;Ann Apolloni;Lindsay Hurren;Denis J. Moss

  • Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.

    A. B. Rlckinson;D. J. Moss;J. H. Pope;N. Ahlberg

Frequent Co-Authors

Scott R. Burrows
Scott R. Burrows QIMR Berghofer Medical Research Institute
Rajiv Khanna
Rajiv Khanna QIMR Berghofer Medical Research Institute
Andreas Suhrbier
Andreas Suhrbier QIMR Berghofer Medical Research Institute
Peter G. Parsons
Peter G. Parsons QIMR Berghofer Medical Research Institute
Alan B. Rickinson
Alan B. Rickinson University of Birmingham
John J. Miles
John J. Miles James Cook University
Maher K. Gandhi
Maher K. Gandhi University of Queensland
James McCluskey
James McCluskey University of Melbourne
David C. Tscharke
David C. Tscharke Australian National University
Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your knowledge through related nursing degrees can open diverse career opportunities. Many professionals consider accelerated nursing programs to fast-track their transition into specialized roles. For example, exploring accelerated RN to NP programs offers an efficient pathway for registered nurses aiming to become nurse practitioners, combining advanced clinical skills with a strong scientific foundation.

Non-nurses looking to enter the healthcare field quickly can benefit from 12-month accelerated nursing programs online for non nurses. These programs provide a fast, flexible option for individuals transitioning into nursing, relevant for Immunology-related patient care roles.

For those just starting out, understanding the options within ABSN programs with high acceptance rates can help in selecting accessible, quality nursing programs that align with career goals.

Additionally, professionals aiming to focus on critical care can consider acquiring acute care nurse practitioner certification. This certification equips nurses with expertise in managing complex immunological and acute health conditions, positioning them for specialized clinical roles.

Best Scientists Citing Denis J. Moss